2hon MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based ...
Adopt AI, accelerate development and increase velocity. With 84% of respondents to the Stack Overflow 2025 Developer Survey ...
Unlock your potential as an automation artist! Learn how Ignition 8.3's new design features allow you to swiftly create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback